The Lancet Oncology in conversation with

The Lancet Oncology in conversation with

Por: The Lancet Group
Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicity, and more.
70 episodios disponibles

Latest episodes of the podcast The Lancet Oncology in conversation with

Andre Pfob and Peter Dubsky on The Lucerne Toolbox 3 25/11/2025
Gary Rodin on The human crisis in cancer: a Lancet Oncology Commission 02/11/2025
Matthias Preusser on the phase 2 TUXEDO-3 trial 27/10/2025
Andrea Necchi on TAR-200 plus cetrelimab as neoadjuvant therapy in patients with muscle-invasive bladder cancer 29/09/2025
Linda Bi, Ruchit Patel, Chloe Gui, Farshad Nassiri, and Matija Snuderl on TERT expression and TERT promoter mutations in meningiomas 02/09/2025
Jinming Li on patterns in genomic mutations among patients with early-onset colorectal cancer 28/07/2025
Abdalla Awidi on cancer control in the Middle East 11/06/2025
ASCO 2025 Debrief 11/06/2025
Caroline Robert on treatments for patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN trial) 28/05/2025
Richard Bryant on transperineal vs transrectal biopsy for prostate cancer 30/04/2025
Professor Amar U. Kishan on HYpofractionateD RAdiotherapy for Prostate Cancer (HYDRA) 31/03/2025
Ariana Znaor on cancer surveillance in the Eastern Mediterranean region 03/03/2025
Ian Tannock on Common Sense Oncology principles for phase 3 randomised clinical trials 03/02/2025
Yannick Romero on the changing landscape of national cancer control plans 02/01/2025
M Saiful Huq and Mostafa Aziz Sumon on the series Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries 02/12/2024
Steven Horwitz on valemetostat for relapsed or refractory T-cell lymphoma 30/10/2024
Zachary Zumsteg on early phase trial design for novel drug-radiotherapy combination 30/09/2024
May Abdel-Wahab and Andrew Scott on The Lancet Oncology Commission on Radiotherapy and Theranostics 30/09/2024
Kanwal Raghav on trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02) 27/08/2024
Emmy Boerrigter on dose selection of novel anticancer drugs 29/07/2024
1 2 3 4 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA